Stocks · Health care · Pharmaceutical Preparations

Roivant Sciences Ltd.

ROIV Clue Score19
Bermuda Fiscal year ends March CIK 0001635088 Results filed 6 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Matthew Gline
18 Sep 2025
CEO
Buy
3,315
$15.07
$49.96K
Showing 250 of 304 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 440
Amendments (4/A) skipped 0
Filings about a different issuer 35
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 10
Sales straight out of an exercise 125
Sales at will 164
Transactions with no price 0
Shares from compensation/vesting 353,199,418
Sales filed before the plan box existed 53
History held since 17 Oct 2017